(S (NP-SBJ (NP (JJ Direct) (NN exposure)) (PP (TO to) (NP (NP (NN 2,3,7,8-tetrachlorodibenzo-p-dioxin)) (PRN (-LRB- -LRB-) (NP (NN TCDD)) (-RRB- -RRB-))))) (VP (VBZ increases) (NP (NP (NN infectivity)) (PP (IN of) (NP (JJ human) (NNS erythrocytes))) (PP (TO to) (NP (DT a) (JJ malarial) (NN parasite))))) (. .))
(S (NP-SBJ (NP (JJ Direct) (NN exposure)) (PP (TO to) (NP (ADJP (CD 10) (NN nM)) (NN 2,3,7,8-TCDD)))) (VP (VBD caused) (NP (NP-COOD (NP (DT a) (CD 75) (NN %) (NN increase)) (CC and) (NP (DT a) (QP (JJ 2-fold)) (NN increase))) (PP (IN in) (NP (NP (DT the) (NN infectivity)) (PP (IN of) (NP (VBN isolated) (JJ human) (NNS erythrocytes))) (PP (TO to) (NP (FW P.) (FW falciparum)))))) (PP-TMP (IN after) (NP (NP (CD 48) (NNS hours)) (SBAR (WHADVP-16 (WRB when)) (S (NP-SBJ (DT the) (NNS parasites)) (VP (VBD were) (PP-PRD (IN in) (NP (NP (DT an) (ADJP-COOD (ADJP (JJ unsynchronized)) (CC or) (ADJP (JJ synchronized))) (NN state)) (PP (IN of) (NP (NN growth))))) (, ,) (ADVP (RB respectively)) (ADVP (-NONE- *T*-16)))))))) (. .))
(S (NP-SBJ (NP (NN Treatment)) (PP (IN of) (NP (JJ human) (NNS erythrocytes))) (PP (IN with) (NP (NP (ADJP (CD 10) (NN microM)) (NP (NP (NN sodium) (NN orthovanadate)) (PRN (-LRB- -LRB-) (NP (NN NaOV)) (-RRB- -RRB-)))) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP-COOD (NP (NN plasma) (NN membrane) (NN Ca-ATPase)) (CC and) (NP (NN phosphotyrosine) (NN phosphatase))))) (, ,)))) (VP (VBD decreased) (NP (NN parasitemia)) (PP (IN by) (NP (CD 30) (NN %)))) (. .))
(S (NP-SBJ (NP (NN Co-treatment)) (PP (IN of) (NP (NNS RBCs))) (PP (IN with) (NP-COOD (NP (NN TCDD)) (CC and) (NP (NN NaOV))))) (ADVP (RB completely)) (VP (VBD blocked) (NP (NP (DT the) (JJ TCDD-induced) (NN increase)) (PP (IN in) (NP (NN parasitemia))))) (. .))
(S (SBAR (IN Because) (S (NP-SBJ-17 (NNS erythrocytes)) (VP (VBP are) (VP (JJ anucleated) (NP (-NONE- *-17)))))) (, ,) (NP-SBJ-18 (DT these) (NNS results)) (VP (VBP are) (VP (VBN discussed) (NP (-NONE- *-18)) (PP (IN as) (NP (NP (NN evidence)) (PP (IN for) (NP (NP (JJ biochemical) (NNS changes)) (PP (IN by) (NP (NN TCDD))) (PP (IN without) (S (NP-SBJ (-NONE- *)) (VP (VBG requiring) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN gene) (NNS products))))))))))))) (. .))
